Protective effect of diltiazem on myocardial ischemic rats induced by isoproterenol

Wei,Yuejiao; Meng,Tianyu; Sun,Chaofeng

doi:10.3892/mmr.2017.7906

Protective effect of diltiazem on myocardial ischemic rats induced by isoproterenol

Authors:
- Yuejiao Wei
- Tianyu Meng
- Chaofeng Sun
View Affiliations

Affiliations: Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
Published online on: October 26, 2017 https://doi.org/10.3892/mmr.2017.7906
Pages: 495-501

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to analyze the effect of diltiazem on myocardial fibrosis and remodeling of connexin43 (Cx43) in myocardial ischemic rats and mechanisms underlying these processes. A total of 36 Sprague‑Dawley rats were randomly allocated into three groups (control, isoproterenol and isoproterenol with diltiazem). The myocardial ischemic model was established by 5 mg/kg/day isoproterenol administration for 7 days, and the diltiazem group received 25 mg/kg/day diltiazem for 4 weeks. Following the treatment, paraffin sections were prepared to observe microstructural changes and to evaluate the concentration of Ca2+ in myocardium. The expression of transforming growth factors‑β1 (TGF‑β1), mothers against decapentaplegic homologues (Smad)2 and 7 and Cx43, were analyzed by reverse transcription-quantitative polymerase chain reaction and western blotting. The percentage Cx43 expression in intercalated disks was evaluated using immunohistochemistry. Fibrosis did not differ significantly between the control and the diltiazem‑treated group. The concentration of Ca2+ increased in the myocardium of model rats. The expression of Smad7 and Cx43 was decreased in the rat model, while the expression of TGF‑β1 and Smad2 was increased. There was a significant decrease in the relative abundance of intercalated disk Cx43 in the model group. The results of the present study suggest that diltiazem may serve a protective role during remodeling of myocardial ischemia, especially in fibrosis and Cx43 remodeling.

View Figures

View References

1	Pimple P, Shah AJ, Rooks C, Bremner Douglas J, Nye J, Ibeanu I, Raggi P and Vaccarino V: Angina and mental stress-induced myocardial ischemia. J Psychosom Res. 78:433–437. 2015. View Article : Google Scholar : PubMed/NCBI
2	Wu H, Ye M, Yang J and Ding J: Endoplasmic reticulum stress-induced apoptosis: A possible role in myocardial ischemia-reperfusion injury. Int J Cardiol. 208:65–66. 2016. View Article : Google Scholar : PubMed/NCBI
3	Shintani-Ishida K and Yoshida K: Mitochondrial m-calpain opens the mitochondrial permeability transition pore in ischemia-reperfusion. Int J Cardiol. 197:26–32. 2015. View Article : Google Scholar : PubMed/NCBI
4	Eguchi A, Naito Y, Iwasaku T, Okuhara Y, Morisawa D, Sawada H, Nishimura K, Oboshi M, Fujii K, Mano T, et al: Association of dietary iron restriction with left ventricular remodeling after myocardial infarction in mice. Heart Vessels. 31:222–229. 2016. View Article : Google Scholar : PubMed/NCBI
5	Zhang X, Ambale-Venkatesh B, Bluemke DA, Cowan BR, Finn JP, Kadish AH, Lee DC, Lima JA, Hundley WG, Suinesiaputra A, et al: Information maximizing component analysis of left ventricular remodeling due to myocardial infarction. J Transl Med. 13:3432015. View Article : Google Scholar : PubMed/NCBI
6	Travers JG, Kamal FA, Robbins J, Yutzey KE and Blaxall BC: Cardiac fibrosis: The fibroblast awakens. Circ Res. 118:1021–1040. 2016. View Article : Google Scholar : PubMed/NCBI
7	Hayden MR, Chowdhury N, Govindarajan G, Karuparthi PR, Habibi J and Sowers JR: Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome. J Cardiometab Syndr. 1:326–333. 2006. View Article : Google Scholar : PubMed/NCBI
8	McLenachan JM and Dargie HJ: Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens. 3:735–740. 1990. View Article : Google Scholar : PubMed/NCBI
9	Jiang F, Liu GS, Dusting GJ and Chan EC: NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses. Redox Biol. 2:267–272. 2014. View Article : Google Scholar : PubMed/NCBI
10	Samarakoon R, Overstreet JM and Higgins PJ: TGF-β signaling in tissue fibrosis: Redox controls, target genes and therapeutic opportunities. Cell Signal. 25:264–268. 2013. View Article : Google Scholar : PubMed/NCBI
11	Tandon A, Tovey JC, Sharma A, Gupta R and Mohan RR: Role of transforming growth factor Beta in corneal function, biology and pathology. Curr Mol Med. 10:565–578. 2010. View Article : Google Scholar : PubMed/NCBI
12	Kato T, Iwasaki YK and Nattel S: Connexins and atrial fibrillation: Filling in the gaps. Circulation. 125:203–206. 2012. View Article : Google Scholar : PubMed/NCBI
13	Lambiase PD and Tinker A: Connexins in the heart. Cell Tissue Res. 360:675–684. 2015. View Article : Google Scholar : PubMed/NCBI
14	Borger MA and Weisel RD: Calcium channel blockers in myocardial and cerebral ischemia: A clinician's review from bench to bedside. Can J Cardiol. 15:333–340. 1999.PubMed/NCBI
15	Ohyama Y, Funao K, Kawabe E, Hayashi D, Yamazaki T, Iga T, Koide D, Ohe K and Kubota K: Calcium channel blockers and myocardial infarction: A case-control study in a Japanese hospital. Pharmacoepidemiol Drug Saf. 11:487–492. 2002. View Article : Google Scholar : PubMed/NCBI
16	Williams D, Kim KS and Adams-Campbell LL: Survival benefit from calcium channel blockers in elderly blacks following acute myocardial infarction. Ethn Dis. 12:229–233. 2002.PubMed/NCBI
17	Zhang YG, Li YG, Liu BG, Wei RH, Wang DM, Tan XR, Bu DF, Pang YZ and Tang CS: Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol. Acta Pharmacol Sin. 28:36–43. 2007. View Article : Google Scholar : PubMed/NCBI
18	Hori Y, Kunihiro S, Sato S, Yoshioka K, Hara Y, Kanai K, Hoshi F, Itoh N and Higuchi S: Doxycycline attenuates isoproterenol-induced myocardial fibrosis and matrix metalloproteinase activity in rats. Biol Pharm Bull. 32:1678–1682. 2009. View Article : Google Scholar : PubMed/NCBI
19	Ferreira AJ, Santos RA and Almeida AP: Angiotensin-(1–7): Cardioprotective effect in myocardial ischemia/reperfusion. Hypertension. 38:665–668. 2001. View Article : Google Scholar : PubMed/NCBI
20	Axelsen LN, Calloe K, Braunstein TH, Riemann M, Hofgaard JP, Liang B, Jensen CF, Olsen KB, Bartels ED, Baandrup U, et al: Diet-induced pre-diabetes slows cardiac conductance and promotes arrhythmogenesis. Cardiovasc Diabetol. 14:872015. View Article : Google Scholar : PubMed/NCBI
21	Kudo-Sakamoto Y, Akazawa H, Ito K, Takano J, Yano M, Yabumoto C, Naito AT, Oka T, Lee JK, Sakata Y, et al: Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling. J Biol Chem. 289:19408–19419. 2014. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Nademanee K, Raju H, de Noronha SV, Papadakis M, Robinson L, Rothery S, Makita N, Kowase S, Boonmee N, Vitayakritsirikul V, et al: Fibrosis, connexin-43, and conduction abnormalities in the brugada syndrome. J Am Coll Cardiol. 66:1976–1986. 2015. View Article : Google Scholar : PubMed/NCBI
24	Dorado Garcia D, Ruiz-Meana M, Inserte J, Rodriguez-Sinovas A and Piper HM: Calcium-mediated cell death during myocardial reperfusion. Cardiovasc Res. 94:168–180. 2012. View Article : Google Scholar : PubMed/NCBI
25	Bloom S and Davis DL: Calcium as mediator of isoproterenol-induced myocardial necrosis. Am J Pathol. 69:459–470. 1972.PubMed/NCBI
26	Monasky MM, Varian KD and Janssen PM: Gender comparison of contractile performance and beta-adrenergic response in isolated rat cardiac trabeculae. J Comp Physiol B. 178:307–313. 2008. View Article : Google Scholar : PubMed/NCBI
27	Hori Y, Uechi M, Ebisawa T, Yamano S, Yoshioka K and Mutoh K: The influence of gender on cardiac fibrosis induced by sympathetic stimulation. Chin J Physiol. 51:146–151. 2008.PubMed/NCBI
28	Singal PK, Beamish RE and Dhalla NS: Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol. 161:391–401. 1983. View Article : Google Scholar : PubMed/NCBI
29	Glukhov AV, Balycheva M, Sanchez-Alonso JL, Ilkan Z, Alvarez-Laviada A, Bhogal N, Diakonov I, Schobesberger S, Sikkel MB, Bhargava A, et al: Direct evidence for microdomain-specific localization and remodeling of functional L-type calcium channels in rat and human atrial myocytes. Circulation. 132:2372–2384. 2015. View Article : Google Scholar : PubMed/NCBI
30	Olwin BB and Storm DR: Calcium binding to complexes of calmodulin and calmodulin binding proteins. Biochemistry. 24:8081–8086. 1985. View Article : Google Scholar : PubMed/NCBI
31	Pang X and Sun NL: Calcineurin-NFAT signaling is involved in phenylephrine-induced vascular smooth muscle cell proliferation. Acta Pharmacol Sin. 30:537–544. 2009. View Article : Google Scholar : PubMed/NCBI
32	Kalyanasundaram A, Lacombe VA, Belevych AE, Brunello L, Carnes CA, Janssen PM, Knollmann BC, Periasamy M and Gyørke S: Up-regulation of sarcoplasmic reticulum Ca(2+) uptake leads to cardiac hypertrophy, contractile dysfunction and early mortality in mice deficient in CASQ2. Cardiovasc Res. 98:297–306. 2013. View Article : Google Scholar : PubMed/NCBI
33	Wei HY, Guo ZQ and Cui SJ: Apocalmodulin and Ca²⁺−independent calmodulin-binding proteins. Prog Biochem Biophys. 34:124–131. 2007.(In Chinese).
34	Wei LH, Huang XR, Zhang Y, Li YQ, Chen HY, Heuchel R, Yan BP, Yu CM and Lan HY: Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension. PLoS One. 8:e701952013. View Article : Google Scholar : PubMed/NCBI
35	Icekson Kessler G, Schlesinger H, Freimann S and Kessler E: Expression of procollagen C-proteinase enhancer-1 in the remodeling rat heart is stimulated by aldosterone. Int J Biochem Cell Biol. 38:358–365. 2006. View Article : Google Scholar : PubMed/NCBI
36	Saffitz JE: Douglas P. Zipes Lecture. Biology and pathobiology of cardiac connexins: From cell to bedside. Heart Rhythm. 3:102–107. 2006. View Article : Google Scholar : PubMed/NCBI
37	Söhl G and Willecke K: Gap junctions and the connexin protein family. Cardiovasc Res. 62:228–232. 2004. View Article : Google Scholar : PubMed/NCBI
38	Severs NJ, Bruce AF, Dupont E and Rothery S: Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res. 80:9–19. 2008. View Article : Google Scholar : PubMed/NCBI
39	Halidi N, Alonso F, Burt JM, Bény JL, Haefliger JA and Meister JJ: Intercellular calcium waves in primary cultured rat mesenteric smooth muscle cells are mediated by connexin43. Cell Commun Adhes. 19:25–37. 2012. View Article : Google Scholar : PubMed/NCBI
40	Lurtz MM and Louis CF: Intracellular calcium regulation of connexin43. Am J Physiol Cell Physiol. 293:C1806–C1813. 2007. View Article : Google Scholar : PubMed/NCBI
41	Goll DE, Thompson VF, Li H, Wei W and Cong J: The calpain system. Physiol Rev. 83:731–801. 2003. View Article : Google Scholar : PubMed/NCBI
42	Zhang W, Ma X, Zhong M, Zheng Z, Li L, Wang Z and Zhang Y: Role of the Calpain system in pulmonary vein connexin remodeling in dogs with atrial fibrillation. Cardiology. 112:22–30. 2009. View Article : Google Scholar : PubMed/NCBI
43	Anderson ME: Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias? Trends Cardiovasc Med. 14:152–161. 2004. View Article : Google Scholar : PubMed/NCBI
44	Kröner A, Seitelberger R, Schirnhofer J, Bernecker O, Mallinger R, Hallström S, Ploner M and Podesser BK: Diltiazem during reperfusion preserves high energy phosphates by protection of mitochondrial integrity. Eur J Cardiothorac Surg. 21:224–231. 2002. View Article : Google Scholar : PubMed/NCBI
45	Hegde A, Amaria T, Mandke A and Mandke NV: Comparative study of perioperative infusion of diltiazem and nicorandil on myocardial protection during OPCAB surgery. Ann Card Anaesth. 8:49–54. 2005.PubMed/NCBI
46	Chouairi S, Carrie D and Puel J: Myocardial protection with calcium-channel blockers during ischaemia and reperfusion by PTCA. Eur Heart J. 16 Suppl H:S3–S8. 1995. View Article : Google Scholar
47	Rousseau G, Provost P and Latour JG: Sustained myocardial protection by clentiazem (TA-3090) after a 90-minute coronary occlusion and 72 hours of reperfusion in dogs with collateral flow. J Cardiovasc Pharmacol. 22:264–272. 1993. View Article : Google Scholar : PubMed/NCBI